SNAQ Launches the First AI Nutritionist for CGM Users Managing Diabetes

SNAQ Launches the First AI Nutritionist for CGM Users Managing Diabetes

by | Mar 19, 2026 | Innovation, Press Release, Research

Back to News

SNAQ Launches the First AI Nutritionist for CGM Users Managing Diabetes

SNAQ has announced the release of its AI Nutritionist, a first-of-its-kind digital companion designed to help people with diabetes.

SNAQ has launched its AI Nutritionist, a digital companion designed to support people with diabetes through personalized, real-time nutrition guidance. By integrating meal analysis, glucose data, insulin, and activity tracking, the tool delivers tailored recommendations and always-on coaching to help users improve blood sugar control and build sustainable habits.

Built on SNAQ’s clinically validated meal recognition technology, already used by over 250,000 people, the platform is supported by randomized-controlled evidence showing improved glycemic outcomes. CEO Aurelian Briner highlighted its potential to expand access to affordable, high-quality nutrition care globally. The AI Nutritionist is now available in the U.S., with international rollout planned throughout 2026.

For more details, visit the full press release or explore SNAQ’s website to learn more about their AI-driven diabetes care solutions.

More recent news

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz

info@dcberne.com

Impressum

Datenschutzerklärung

DCB Innovation Bootcamp 2026 | Apply now!

DCB Innovation Bootcamp 2026 | Apply now!

by | Mar 12, 2026 | Innovation

Back to News

DCB Innovation Bootcamp 2026 | Apply now!

31 Aug – 3 Sep · Emmetten, Switzerland
An immersive accelerator for diabetes technology founders in the Swiss Alps

Why this Bootcamp

For five years, DCB’s Innovation Challenge brought the global diabetes innovation community together, engaging more than 350 startups. The resounding feedback: the Bootcamp delivered the highest impact. In 2026, we’re focusing entirely on that experience – intense, practical, and personal. 

Who should apply

Startups building diabetes technology – devices, software, digital health, data/AI, UX, clinical tools. Open to all stages from MVP to early scale, with teams ready to engage deeply. Past DCB Challenge participants are welcome. 

Be a part of this impactful accelerator

Apply now!

Contact

Ema Grabenweger

Program Lead

ema.grabenweger@dcberne.com

What you’ll experience

Founders & Industry

  • Founder journeys – successes, failures and lessons learned  
  • Industry insights

    Product & Users

    • Software & UX: designing products people will actually use  
    • User-perspective feedback from the diabetes community  

      Clinical & Regulatory

      • Designing clinical trials  
      • Regulatory strategies: navigating FDA and MDR  

        Funding & Communication 

        • Go-to-market considerations  
        • Venture session: what VCs look for  
        • Professional pitch training – leave with a polished 5-minute pitch

           

        Deep dives

        • 1:1 expert sessions tailored to your startup

          Partner spotlight 

          • American Diabetes Association® (ADA): finalists from ADA’s Innovation Challenge join the Bootcamp.  

            Logistics & costs

            • Dates: 31 Aug – 3 Sep 2026  
            • Venue: Seeblick Höhenhotel, Emmetten, Switzerland  
            • Program fee: Covered by DCB  
            • Accommodation: Covered by DCB  
            • Travel: Covered by participants   

            Selection

            We evaluate problem relevance, innovation, clinical impact, feasibility and regulatory thinking, team strength, traction, and cohort fit. Spaces are limited.  

            How to apply

            Send your pitch deck (PDF, ≤15 slides) and a 150–300 word motivation to innovation@dcberne.com by April 30, 23:59 CEST. 

            Important dates

            Application close: April 30, 23:59 CEST
            Decisions: May 15, 2026

            Bootcamp: 31 Aug – 3 Sep 2026

            Apply now!

            FAQs

            Team size to attend:
            Recommended 2 attendees per startup

            Language:
            English

            Confidentiality:
            1:1s can use NDAs on request

            Sign up for our newsletter
            to receive the latest news.

            * Pflichtfelder
            DSGVO *

            DCB Research AG

            Freiburgstrasse 3
            3010 Bern
            Schweiz

            info@dcberne.com

            Impressum

            Datenschutzerklärung

            Meet us at ATTD!

            Meet us at ATTD!

            by | Mar 5, 2026 | Innovation

            Back to News

            Meet us at ATTD!

            The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

            DCB at ATTD 2026

            The ATTD (Advanced Technologies & Treatments in Diabetes) congress is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Barcelona fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.

            We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful sessions, exploring new innovative solutions and above all: networking with, you!

            Also, we are excited to participate in ATTD Ignite 2026 an exclusive platform designed to foster innovation and collaboration in diabetes technology. This event, taking place on Wednesday, 11 March, from 9:00 CET to 13:00 CET in Hall 212, provides a unique opportunity for startups and researchers to connect, share insights, and accelerate breakthroughs in diabetes technology and patient care. Greta Ehlers, Partnerships & Innovation Lead at DCB, will part of the fireside chat “From Personal Pain to Global Impact: The Journey of Patient-Led Innovation” from 09:05 to 09:35. Later, the DCB spin-off Beyond Diagnostics is pitching at the session “Innovators in Action: Diabetes Tech Tank”.

            Don’t miss these opportunities to gain valuable insights and engage with industry experts!

            If you are attending ATTD and are eager to learn more about our services, our innovation activities, our main research areas, our community, or any other topics – please reach out to us via e-mail. We look forward to connecting with you!

            Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.

            Downloads

            "

            Flyer DCB Summer School 2026

            PDF

            More recent news

            Sign up for our newsletter
            to receive the latest news.

            * Pflichtfelder
            DSGVO *

            DCB Research AG

            Freiburgstrasse 3
            3010 Bern
            Schweiz

            info@dcberne.com

            Impressum

            Datenschutzerklärung